By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardio3 BioSciences 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35



Company News
Cardio3 BioSciences Announces The Enrolment Of The 240th Patient For Its CHART-1 Phase 3 Clinical Trial For The Treatment Of Heart Failure 12/19/2014 8:52:22 AM
Cardio3 BioSciences Will Be Present At ODDO Midcap Forum 12/17/2014 9:49:28 AM
Cardio3 BioSciences To Address American Institutional Investors In January At J.P. Morgan Healthcare Conference 12/15/2014 10:48:35 AM
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014 3:26:39 PM
Cardio3 BioSciences Acquires CorQuest Medical Inc. 11/5/2014 10:35:10 AM
Cardio3 BioSciences Appoints Dr. Warren Sherman As Chief Medical Officer 10/23/2014 9:25:08 AM
Cardio3 BioSciences Receives Authorization To Enroll Patients In Switzerland In Its Phase 3 Clinical Trial Chart-1 10/13/2014 11:37:20 AM
Cardio3 BioSciences Awarded Preferred Access Rights To Mayo Clinic Center For Regenerative Medicine Portfolio 10/8/2014 9:30:10 AM
Cardio3 BioSciences Announces New Business Development Strategy To Broaden Its Product Pipeline 10/1/2014 8:05:58 AM
Cardio3 BioSciences Receives Approval For The Continuation Of Its Chart-1 Phase III Clinical Trial From The DSMB 9/15/2014 11:09:52 AM